The Ethics of Organ Commercialization: Against Legalized Sales
This paper examines the ongoing ethical debate surrounding the commercialization of organ transplantation. It outlines arguments in favor of legalizing organ sales — primarily utilitarian claims that such a market would maximize overall happiness by increasing organ supply and compensating donors — before critiquing those arguments on both philosophical and practical grounds. Drawing on Kantian ethics, the paper argues that commercializing organ transplantation undermines the good will that makes donation morally meaningful, reducing a profound human act to a market transaction. The paper concludes that organ sales should remain illegal, as true moral value in transplantation depends on voluntary, uncompensated giving rather than financial incentive.
- Introduction: Background on organ supply and paper thesis
- The Argument for Selling Organs: Pro-commercialization and life-saving rationale
- Utilitarian Ethics and Its Limits: Utilitarianism examined and critiqued
- The Argument Against the Commercialization of Transplants: Kantian rejection of organ sales
- Kantian Ethics and Good Will: Good will as the sole moral standard
- Conclusion: Kantian ethics affirmed over utilitarian arguments
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper clearly states its thesis early — that organ sales are unethical and should remain illegal — and maintains that position consistently throughout.
- It presents the opposing viewpoint (utilitarian arguments for organ sales) fairly before systematically dismantling them, demonstrating balanced analytical engagement.
- The use of two contrasting ethical frameworks — utilitarianism and Kantian ethics — gives the argument a recognizable philosophical structure that is well suited to a medical ethics topic.
- Citations are distributed across multiple sources and integrated naturally into the argument rather than dropped in at the end of paragraphs.
Key academic technique demonstrated
The paper demonstrates counter-argument and refutation: it devotes a full section to the strongest case for the opposing view before explaining why that case fails. This technique strengthens the writer's own position by showing it has survived scrutiny, rather than simply ignoring objections.
Structure breakdown
The paper opens with background on organ availability and a clear thesis statement. It then presents the pro-commercialization position, grounding it in utilitarian ethics, before identifying the philosophical weaknesses in that framework. The next section develops the Kantian counter-argument, explaining why good will — not outcomes — is the proper measure of moral action in this context. The conclusion synthesizes both sides and reaffirms the Kantian position as the more compelling framework for evaluating organ transplant policy.
Introduction
Throughout the history of organ transplantation, organs have become available in two different ways: when a person who was a registered organ donor has died, and when an organ that can be safely removed from a living body has been offered for donation to a friend or family member. There are also registries for items like bone marrow, which can be donated to someone who is not a friend or family member. However, arguments have also been made that it should be legal to sell organs for transplantation if the individual consents to doing so. These organs could be sold to a particular patient in need, or they could be sold to a medical institution to use with any patient that institution saw fit.
Many people regard such an arrangement as completely acceptable: one person has something another person needs, and the person who has it sells it to the person who needs it. There does not seem to be much concern with that in general commerce, but when it comes to organs, the ethical questions become far more difficult to navigate. There are serious moral implications that do not arise when selling an inanimate object but must be considered when a person contemplates selling a part of himself or herself to another. The sale of organs is wrong and unethical, and should remain against the law despite recent attempts to legalize it.
The Argument for Selling Organs
Those who argue that it is acceptable to commercialize organ transplantation make several points in favor of the practice. These include the claim that organs belong to the person, and if he or she wishes to sell them, it should not be the business of the government or lawmakers to say otherwise. There is also the argument that sellers would be saving lives, and therefore performing a genuinely good deed. The fact that they receive money for this is not, technically, relevant to their argument about saving lives or contributing something positive to society as a whole.
Another argument for selling organs holds that the value of society outweighs the value of any particular individual, and that the person saved by a transplanted organ may go on to contribute far more to society than the person who donated it. This utilitarian belief — that the most happiness is achieved for the greatest number in such a scenario — is the most common moral argument advanced for issues of this nature. In general, most arguments made in favor of organ commercialization follow this ethical framework. However, many philosophers and ethicists have challenged and discredited the assumptions underlying utilitarianism.
Utilitarian Ethics and Its Limits
Utilitarianism holds that the action producing the greatest happiness for everyone involved is the morally correct choice (Brody, 1988; Shaw, 2014). Those who believe that organs should be commercially available for transplantation often invoke this argument because they wish to show that allowing such sales will not only make recipients happy by providing needed organs, but will also make sellers happy by providing money. On the surface, this reasoning appears sound.
However, there is more to the issue than that. Those who argue from utilitarian principles often fail to account for the reasons behind why people make their choices (Epstein, 2009). In other words, they focus only on the happiness they perceive people to have, without examining the problems that alleged happiness may also create (Veatch, 1988). Where medical ethics is concerned, there are many gray areas, and things are rarely as straightforward as they initially seem (Brody, 1988; Epstein, 2009). This complexity is often ignored but should be clearly addressed.
The Argument Against the Commercialization of Transplants
Those who argue against the commercialization of organs for transplantation do not accept the utilitarian argument — that happiness for all is a satisfactory reason for permitting the legal sale of organs. There are too many flaws in that argument to make it a logical basis for this particular issue. Instead, opponents of organ commercialization favor a more Kantian approach. Kant believed that it was not necessary to know the results of a particular choice in order to recognize that the choice was immoral (Shaw, 2014).
In medical ethics, the moral assessment of an action does not always rest on its outcome; often it depends on what must take place throughout the process itself (Brody, 1988). Yes, one person would receive money and another would receive an organ — on its surface, an acceptable trade. Despite that, the exchange of a part of oneself for cash seems, at its core, to be an immoral proposition (Epstein, 2009; Veatch, 1988). The idea that the organs constituting a person's physical body should be for sale to the highest bidder conflicts with fundamental human values in the vast majority of cases, and such transactions should not be viewed in the same manner as selling a house, a car, clothing, or any other inanimate object (Veatch, 1988).
Conclusion
Overall, there are strong arguments both for and against the commercialization of organ transplantation. Despite that, the more compelling argument belongs to Kant, who holds that actions performed out of good will are the only actions that are truly moral. While organ donation is indeed currently carried out with good will, that would change if it were commercialized. There would still be people who donated without asking for or accepting money, but many more people would sell their organs because they needed funds or simply wished to profit. Organ donation would become just another segment of the market.
That outcome might produce happiness for individual participants at the time, and would certainly bring relief to organ recipients whose lives were prolonged as a result. However, it would not contribute to the moral fabric of society or to the quality of genuine good will that Kant described. Those values would be lost in the desire for monetary gain — something that capitalist societies already struggle with to a considerable degree. Giving a part of one's body so that another person may live is a profoundly good act, but only if it is done with true good will toward the other person. There is no room in that moral framework for financial compensation.
References
Brody, B. A. (1988). Life and death decision making. Oxford University Press.
Epstein, S. (2009). Inclusion: The politics of difference in medical research. University of Chicago Press.
Shaw, W. H. (2014). Business ethics (8th ed.). Cengage.
Veatch, R. M. (1988). A theory of medical ethics. Basic Books.
Create your account
Always verify citation format against your institution’s current style guide requirements.